Elixirgen Therapeutics, Inc.
We are advancing our controllable self-replicating RNA (c-srRNA™) technology to develop therapies for a broad spectrum of diseases, rare diseases, aging-related disorders, and cancer.
Last updated on
About Elixirgen Therapeutics, Inc.
Founded
2017Employees
11-50Funding / Mkt. Cap
$26MCategory
Location
City
BaltimoreState
MarylandCountry
United StatesElixirgen Therapeutics, Inc.
Find your buyer within Elixirgen Therapeutics, Inc.
Tech Stack (36)
